Haemostatix wins healthcare award at Royal Society of Chemistry's emerging technologies showcase

1st July 2015 - Thirty finalists from across Europe went head-to-head this week to pitch their ideas for the latest healthcare, energy and sustainability, and materials technologies to panels of industry experts.

The Royal Society of Chemistry’s annual Emerging Technologies Showcase sees more than 200 technologists, scientists and academics attend a day of talks and pitches at Burlington House.

The competition, in its third year, included small companies and academic entrepreneurs from nine countries outside the UK for the first time, including Denmark, Germany, Switzerland and the Netherlands.

Diverse pitches included diagnostic flu tests using gold and sugars, electricity generation from wastewater and wearable energy harvesting fabrics, among many others.

Nottingham-based Haemostatix Ltd took first prize in the healthcare stream for their peptide dendrimer, which treats bleeding during surgery and trauma. In second and third place, were the University of Cambridge, for their cancer therapy using artificial metalloproteins, and CytoFind Diagnostics, for their picoliter droplets for detection of circulating tumour cells.